ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Emcure completed the acquisition of a 12.05% stake in Gennova Biopharmaceuticals for ₹231.87 Crore, making it a wholly-owned subsidiary.
Emcure Pharmaceuticals acquires 12.05% minority stake in Gennova Biopharmaceuticals, making it a wholly-owned subsidiary. The move consolidates ownership to sharpen focus on biologics.
Emcure Pharmaceuticals will acquire a 12.05% stake in Gennova Biopharmaceuticals for Rs. 231.87 Crore. This transaction will make Gennova a wholly-owned subsidiary by July 2026.
Emcure's subsidiary, Gennova Biopharmaceuticals, will sell its mRNA business to Immunoscript Life Science for Rs. 139.5 Crore. The slump sale aligns with strategic business reorganization.